Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trialAchim Rittmeyer, David R. Gandara, Fabrice Barlési et al.|The Lancet|2016Cited by 4.8k
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227Julie R. Brahmer, Suresh S. Ramalingam, Adam Płużański et al.|Journal of Clinical Oncology|2022Cited by 375
Surgical Indication for Non-curative Endoscopic Resection in Early Gastric CancerKeun Won Ryu, Jae-Moon Bae, Il Ju Choi et al.|Annals of Surgical Oncology|2007Cited by 95
Sentinel Node Biopsy Using Dye and Isotope Double Tracers in Early Gastric CancerJun Ho Lee, Jae-Moon Bae, Chan Gyoo Kim et al.|Annals of Surgical Oncology|2006Cited by 48